2,286 results match your criteria: "Stanford Cancer Institute.[Affiliation]"

Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues.

Eur J Med Chem

December 2024

Department of Chemical and Systems Biology, ChEM-H and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA, USA. Electronic address:

Chemically induced proximity modalities such as targeted protein degradation (TPD) hold promise for expanding the number of proteins that can be manipulated pharmacologically. However, current TPD strategies are often limited to proteins with preexisting ligands. Molecular glues (e.

View Article and Find Full Text PDF

Esophageal organoids from a variety of pathologies including cancer are grown in Advanced Dulbecco's Modified Eagle Medium-Nutrient Mixture F12 (hereafter ADF). However, the currently available ADF-based formulations are suboptimal for normal human esophageal organoids, limiting the ability to compare normal esophageal organoids with those representing a given disease state. We have utilized immortalized normal human esophageal epithelial cell (keratinocyte) lines EPC1 and EPC2 and endoscopic normal esophageal biopsies to generate three-dimensional (3D) organoids.

View Article and Find Full Text PDF

Background: FLASH radiation therapy (RT) offers a promising avenue for the broadening of the therapeutic index. However, to leverage the full potential of FLASH in the clinical setting, an improved understanding of the biological principles involved is critical. This requires the availability of specialized equipment optimized for the delivery of conventional (CONV) and ultra-high dose rate (UHDR) irradiation for preclinical studies.

View Article and Find Full Text PDF

Aldehyde dehydrogenase (ALDH) is an enzyme responsible for converting aldehyde functional groups into carboxylate metabolites. Elevated ALDH activity is a characteristic feature of cancer stem-like cells (CSCs). As a novel approach to target the CSC trait of overexpressing ALDH, we aimed to utilize ALDH activity for the selective accumulation of a photosensitizer in ALDH CSCs.

View Article and Find Full Text PDF

Rarity & Risk of Secondary Hematologic Neoplasms after CAR T-cell Therapies.

Transplant Cell Ther

October 2024

Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, 94305, USA.

View Article and Find Full Text PDF
Article Synopsis
  • Myelodysplastic neoplasms/syndromes (MDS) are a diverse set of diseases marked by ineffective blood cell production.
  • Recent classification systems by the World Health Organization and the International Consensus have provided more detailed categorizations of MDS based on morphology and genetics.
  • A comprehensive and systematic approach is essential for the accurate diagnosis and classification of MDS, as outlined by the International Consortium for MDS (icMDS).
View Article and Find Full Text PDF
Article Synopsis
  • A study evaluated the effectiveness and safety of cabozantinib in combination with atezolizumab compared to cabozantinib alone in patients with advanced non-small cell lung cancer (NSCLC) who had previously received an immune checkpoint inhibitor (ICI).
  • The phase 1b COSMIC-021 trial included stage IV non-squamous NSCLC patients who progressed on an ICI, assessing treatment response and safety profiles for both groups.
  • Results showed a modest objective response rate of 20% for the combination therapy and 6% for the single-agent treatment, with high rates of treatment-related adverse events but manageable toxicity overall.
View Article and Find Full Text PDF

Targeted protein degradation and induced proximity refer to strategies that leverage the recruitment of proteins to facilitate their modification, regulation or degradation. As prospective design of glues remains challenging, unbiased discovery methods are needed to unveil hidden chemical targets. Here we establish a high throughput affinity purification mass spectrometry workflow in cell lysates for the unbiased identification of molecular glue targets.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists are studying the DNA of tigers to understand their genetic diversity and help protect them, especially since many tigers in the wild are endangered.
  • This research looks at tigers that are kept in captivity, like privately owned ones in the U.S., known as "Generic" tigers, which might have mixed ancestry from different tiger types.
  • The study found that these Generic tigers have similar genetic diversity to wild tigers and can help conservation efforts by creating a new way to identify tiger ancestry using less expensive genetic testing methods.
View Article and Find Full Text PDF
Article Synopsis
  • Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have limited treatment options, prompting the investigation of magrolimab (M) combined with rituximab (R), and M combined with gemcitabine-oxaliplatin (M+R-GemOx) for long-term disease control.
  • In a study involving 132 patients, M+R achieved an objective response rate (ORR) of 24%, while M+R-GemOx showed a higher ORR of 52%, with notable complete response (CR) rates of 12% and 39%, respectively.
  • Both treatments were generally well tolerated, though common side effects included fatigue and anemia, with
View Article and Find Full Text PDF
Article Synopsis
  • The KEYNOTE-671 trial showed that adding pembrolizumab to neoadjuvant chemotherapy significantly enhanced event-free survival in patients with early-stage non-small-cell lung cancer (NSCLC).
  • The trial involved randomizing nearly 800 participants across 189 medical centers, comparing treatment with pembrolizumab plus chemotherapy against a placebo plus chemotherapy.
  • Results indicated that after 36 months, overall survival was higher in the pembrolizumab group (71%) compared to the placebo group (64%), suggesting a positive impact of the immunotherapy.
View Article and Find Full Text PDF

Doublecortin-like kinase 1 (DCLK1) is a proposed driver of gastric cancer (GC) that phosphorylates serine and threonine residues. Here, we showed that the kinase activity of DCLK1 orchestrated cancer cell-intrinsic and-extrinsic processes that led to pro-invasive and pro-metastatic reprogramming of GC cells. Inhibition of the kinase activity of DCLK1 reduced the growth of subcutaneous xenograft tumors formed from MKN1 human gastric carcinoma cells in mice and decreased the abundance of the stromal markers α-Sma, vimentin, and collagen.

View Article and Find Full Text PDF

Extrachromosomal DNA (ecDNA) is a hallmark of aggressive cancer, contributing to both oncogene amplification and tumor heterogeneity. Here, we used Hi-C, super-resolution imaging, and long-read sequencing to explore the nuclear architecture of -amplified ecDNA in colorectal cancer cells. Intriguingly, we observed frequent spatial proximity between ecDNA and 68 repetitive elements which we called ecDNA-interacting elements or EIEs.

View Article and Find Full Text PDF

Purpose: Early-stage endometrial cancer is often treated with hysterectomy followed by adjuvant vaginal cuff brachytherapy (VCB). Financial toxicity from cancer treatment can impact treatment completion. The Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared to Standard of Care trial is a multicenter, prospective randomized trial of standard of care (SoC) VCB doses delivered in 3 to 5 fractions per the physician's discretion compared with a 2-fraction course.

View Article and Find Full Text PDF

Proceedings of the 1st biannual bridging the gaps in lung cancer conference.

Oncologist

September 2024

Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA, United States.

Lung cancer is the leading cause of cancer death in the US and globally. The mortality from lung cancer has been declining, due to a reduction in incidence and advances in treatment. Although recent success in developing targeted and immunotherapies for lung cancer has benefitted patients, it has also expanded the complexity of potential treatment options for health care providers.

View Article and Find Full Text PDF
Article Synopsis
  • * A multidisciplinary team of experts from various medical fields contributes to these guidelines, ensuring comprehensive care for patients with cancer-associated VTE.
  • * The guidelines provide specific evaluation processes and recommended treatment options tailored to the different types of cancer-associated VTE.
View Article and Find Full Text PDF
Article Synopsis
  • * These guidelines are designed to support physicians in making informed decisions about CRC screening for patients who do not have specific genetic syndromes.
  • * Recent updates include insights on both primary and secondary CRC prevention, particularly addressing when to start screening for average-risk individuals and those with a relevant personal history of cancer.
View Article and Find Full Text PDF

An innovative, case-based continuing medical education course, Health After Cancer: Cancer Survivorship for Primary Care, was developed to engage clinicians in cancer survivorship care. A post-course survey measured the educational impact of the course on learners' intentions to change practice and changes in attitudes related to interprofessional collaborative practice. Qualitative analysis of free text responses was performed using the immersion-crystallization method.

View Article and Find Full Text PDF

Purpose: Small cell lung cancer (SCLC) is characterized by rapid progression after platinum resistance. Circulating tumor (ctDNA) dynamics early in treatment may help determine platinum sensitivity.

Materials And Methods: Serial plasma samples were collected from patients receiving platinum-based chemotherapy for SCLC on the first 3 days of cycle one and on the first days of subsequent cycles with paired samples collected both before and again after infusions.

View Article and Find Full Text PDF

Hypofractionated radiation therapy regimens should not be used as standard of care for localized soft tissue sarcoma.

View Article and Find Full Text PDF

Background: Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive breast cancer (IBC). Studies have indicated differences in DCIS outcome based on race or ethnicity, but molecular differences have not been investigated.

Methods: We examined the molecular profile of DCIS by self-reported race (SRR) and outcome groups in Black (n = 99) and White (n = 191) women in a large DCIS case-control cohort study with longitudinal follow up.

View Article and Find Full Text PDF